advertisement
Abstract #79502 Published in IGR 20-2
Etiology and management of the hypertensive phase in glaucoma drainage-device surgery
Fargione RA; Tansuebchueasai N; Lee R; Tania Tai TYSurvey of Ophthalmology 2019; 64: 217-224
Insertion of glaucoma drainage devices has become a mainstay in the surgical management of multiple forms of glaucoma, and the indications for this procedure continue to expand. A unique clinical challenge in the postoperative care of these devices is the hypertensive phase, a period of postoperative intraocular pressure elevation in the first three months after surgery. We discuss the influence of a variety of factors on the development of the hypertensive phase after glaucoma drainage implantation, including type of device, device material, and device surface area. Furthermore, several intraoperative and postoperative interventions are investigated as attempts to mitigate this phenomenon. Included among these are the use of antimetabolites, collagen matrix, and a variety of approaches to postoperative inflammation and intraocular pressure control. We provide an overview of our current knowledge of the etiology and management of the hypertensive phase.
New York Eye and Ear Infirmary of Mount Sinai, New York, New York, USA. Electronic address: fargione@post.harvard.edu.
Full articleClassification:
12.8.2 With tube implant or other drainage devices (Part of: 12 Surgical treatment > 12.8 Filtering surgery)
